Study on the Incidence of Intussusception (IS) in Children Aged < 12 Months in Japan
Observational Database Study on the Incidence of Intussusception in Children Aged < 12 Months in Japan
1 other identifier
observational
54
0 countries
N/A
Brief Summary
This study aims to analyse baseline data on IS in order to monitor the possibility of increased risk of IS in children aged \<12 months after introduction of the Rotarix vaccination in Japan.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2011
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2011
CompletedFirst Submitted
Initial submission to the registry
November 22, 2011
CompletedFirst Posted
Study publicly available on registry
November 24, 2011
CompletedOctober 22, 2012
October 1, 2012
Same day
November 22, 2011
October 18, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Occurrence of IS in subjects aged < 12 months
Between January 2005 and April 2011 (6 years)
Occurrence of age-specific and gender-specific incidence of IS among subjects aged < 12 months in Japan
Between January 2005 and April 2011 (6 years)
Secondary Outcomes (2)
Number of IS cases hospitalized more than once among subjects aged < 12 months.
Between January 2005 and April 2011 (6 years)
Occurrence of IS cases by calendar months and year among subjects aged < 12 months
Between January 2005 and April 2011 (6 years)
Study Arms (1)
Case Group
Children aged \< 12 months presenting with IS and covered by the Japan Medical Data Centre Company Limited (JMDC), Tokyo referred to as the JMDC Medical Data Bank (JMDC-MDB).
Interventions
Data source will be the Japan Medical Data Centre Company Limited (JMDC) - JMDC Medical Data Bank (JMDC-MDB) database. Aggregated data (age in months and years and gender) for all subjects recorded in the database and subject-level data for IS cases will be extracted from the database. This database will be reviewed to extract data for the period between January 2005 and April 2011. Cases of IS will be identified using the International Classification of Diseases-10 (ICD-10) diagnostic codes, examination codes and procedural codes.
Eligibility Criteria
Children aged \<12 months presenting with IS and covered by the JMDC-MDB database from January 2005 to April 2011.
You may qualify if:
- A male or female infant aged \< 12 months at the time of IS diagnosis and affiliated to the JMDC-MDB database.
- An IS case should be identified as per the ICD-10 diagnostic code-K56.1 (any-field listed), examination codes, and procedural codes.
You may not qualify if:
- Not applicable
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- GlaxoSmithKlinelead
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
GSK Clinical Trials
GlaxoSmithKline
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 22, 2011
First Posted
November 24, 2011
Study Start
November 1, 2011
Primary Completion
November 1, 2011
Study Completion
November 1, 2011
Last Updated
October 22, 2012
Record last verified: 2012-10